These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 29547874)

  • 1. An analysis of the predictive value of the HIV Ag/Ab screening assay within the performance characteristics of the DiaSorin LIAISON XL for the detection of blood-borne viruses.
    Thai KTD; Götz H; Slingerland BCGC; Klaasse J; Schutten M; GeurtsvanKessel CH
    J Clin Virol; 2018 May; 102():95-100. PubMed ID: 29547874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
    Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
    J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening tests for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus in blood donors: evaluation of two chemiluminescent immunoassay systems.
    Sommese L; Sabia C; Paolillo R; Parente D; Capuano M; Iannone C; Cavalca F; Schiano C; Vasco M; De Pascale MR; Casamassimi A; Napoli C
    Scand J Infect Dis; 2014 Sep; 46(9):660-4. PubMed ID: 25073538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of Liaison XL automated immunoassay platform for blood-borne infection screening on hepatitis B, hepatitis C, HIV 1/2, HTLV 1/2 and Treponema pallidum serological markers.
    Malm K; Kragsbjerg E; Andersson S
    Transfus Med; 2015 Apr; 25(2):101-5. PubMed ID: 25779614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of LIAISON® XL system for HBsAg, and anti-HCV and anti-HIV/Ag p24.
    De Paschale M; Manco MT; Belvisi L; Cagnin D; Cerulli T; Paganini A; Arpino O; Cianflone A; Agrappi C; Mirri P; Clerici P
    J Med Virol; 2017 Mar; 89(3):489-496. PubMed ID: 27467710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical performances of simultaneous detection of HIV-1, HIV-2 and hepatitis C- specific antibodies and hepatitis B surface antigen (HBsAg) by multiplex immunochromatographic rapid test with serum samples: A cross-sectional study.
    Robin L; Mboumba Bouassa RS; Nodjikouambaye ZA; Charmant L; Matta M; Simon S; Filali M; Mboup S; Bélec L
    J Virol Methods; 2018 Mar; 253():1-4. PubMed ID: 29208530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of repeat testing in Turkish blood donors screened with HBV, HCV and HIV immunoassays and the importance of S/CO ratios in the interpretation of HCV/HIV screening test results and as a determinant for further confirmatory testing.
    Acar A; Kemahli S; Altunay H; Kosan E; Oncul O; Gorenek L; Cavuslu S
    Transfus Med; 2010 Jun; 20(3):152-9. PubMed ID: 20059750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of four commercial analyzers for the serological screening of hepatitis A, B, C and HIV.
    Kutvonen H; Jarva H; Lappalainen M; Kurkela S
    J Clin Virol; 2022 Aug; 153():105219. PubMed ID: 35753174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
    Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining rapid diagnostic tests and dried blood spot assays for point-of-care testing of human immunodeficiency virus, hepatitis B and hepatitis C infections in Burkina Faso, West Africa.
    Kania D; Bekalé AM; Nagot N; Mondain AM; Ottomani L; Meda N; Traoré M; Ouédraogo JB; Ducos J; Van de Perre P; Tuaillon E
    Clin Microbiol Infect; 2013 Dec; 19(12):E533-41. PubMed ID: 23902574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of hepatitis B surface antigen with the novel DiaSorin LIAISON XL Murex HBsAg Quant: correlation with the ARCHITECT quantitative assays.
    Burdino E; Ruggiero T; Proietti A; Milia MG; Olivero A; Caviglia GP; Marietti M; Rizzetto M; Smedile A; Ghisetti V
    J Clin Virol; 2014 Aug; 60(4):341-6. PubMed ID: 24930708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New automated chemiluminescence immunoassay for simultaneous but separate detection of human immunodeficiency virus antigens and antibodies.
    Alonso R; López Roa P; Suárez M; Bouza E
    J Clin Microbiol; 2014 May; 52(5):1467-70. PubMed ID: 24574285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the dried blood spot (DBS) collection method as a tool for detection of HIV Ag/Ab, HBsAg, anti-HBs and anti-HCV in a Malaysian tertiary referral hospital.
    Lee CE; Sri Ponnampalavanar S; Syed Omar SF; Mahadeva S; Ong LY; Kamarulzaman A
    Ann Acad Med Singap; 2011 Oct; 40(10):448-53. PubMed ID: 22206053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opt-Out Panel Testing for HIV, Hepatitis B and Hepatitis C in an Urban Emergency Department: A Pilot Study.
    O'Connell S; Lillis D; Cotter A; O'Dea S; Tuite H; Fleming C; Crowley B; Fitzgerald I; Dalby L; Barry H; Shields D; Norris S; Plunkett PK; Bergin C
    PLoS One; 2016; 11(3):e0150546. PubMed ID: 26967517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Short communication: comparison of two different assays for the investigation of HBsAG, anti-HCV and anti-HIV in blood donors].
    Cavdar E; Kuştimur S; Doğruman Al F
    Mikrobiyol Bul; 2006 Oct; 40(4):363-7. PubMed ID: 17205694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
    Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
    J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.
    Bhattacharya P; Chandra PK; Datta S; Banerjee A; Chakraborty S; Rajendran K; Basu SK; Bhattacharya SK; Chakravarty R
    World J Gastroenterol; 2007 Jul; 13(27):3730-3. PubMed ID: 17659734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Head-to-head comparison between two screening systems for HBsAG, anti-HBc, anti-HCV and HIV combination immunoassays in an international, multicentre evaluation study.
    Schmidt M; Jimenez A; Mühlbacher A; Oota S; Blanco L; Sakuldamrongpanich T; Schennach H; Seifried E
    Vox Sang; 2015 Aug; 109(2):114-21. PubMed ID: 25899479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Head-to-head comparison of Enzyme Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence Immunoassay (ECLIA) for the detection of Transfusion Transmitted Disease (TTD) Markers; HIV, HCV and HBV in blood donors, in India.
    Tiwari AK; Upadhyay AP; Arora D; Wadhwa T; Aggarwal G; Pabbi S; Luthra AS; Rawat SS
    J Virol Methods; 2020 Nov; 285():113962. PubMed ID: 32860798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.